Synova Life Sciences Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Synova Life Sciences General Information
Description
Developer of a fat processing device designed to harvest autologous stem cells for treatment. The company's system processes adipose-derived tissue to isolate stem cells while preserving their regenerative properties, enabling physicians to utilize patient-derived cells for therapeutic applications in managing degenerative conditions and promoting tissue repair.
Contact Information
Website
www.synovalife.comCorporate Office
- 686 South Fair Oaks Avenue
- Pasadena, CA 91105
- United States
Corporate Office
- 686 South Fair Oaks Avenue
- Pasadena, CA 91105
- United States
Synova Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | Completed | Startup | ||||
| 9. Later Stage VC | 01-Jun-2023 | Completed | Startup | |||
| 8. Accelerator/Incubator | 15-Jul-2022 | Completed | Startup | |||
| 7. Secondary Transaction - Private | 24-Jan-2022 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 5. Seed Round | 31-Aug-2021 | Completed | Startup | |||
| 4. Seed Round | 15-Jul-2020 | Completed | Startup | |||
| 3. Accelerator/Incubator | $150K | Completed | Startup | |||
| 2. Accelerator/Incubator | 18-Mar-2019 | $150K | $150K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Synova Life Sciences Patents
Synova Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2884348-T3 | Cell separation, dissociation and / or disaggregation using mechanical impacts | Active | 17-Mar-2016 | ||
| EP-3872164-B1 | Isolating stem cells from adipose tissue | Active | 17-Mar-2016 | ||
| EP-3872164-C0 | Isolating stem cells from adipose tissue | Active | 17-Mar-2016 | ||
| ES-2964374-T3 | Isolation of stem cells from adipose tissue | Active | 17-Mar-2016 | ||
| EP-3430122-B1 | Separation, dissociation and/or disaggregation of cells using mechanical impacts | Active | 17-Mar-2016 | C12N5/0667 |
Synova Life Sciences Signals
Synova Life Sciences Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| McNamara Investments | Family Office | Minority | ||
| Unpopular Ventures | Venture Capital | Minority | ||
| Seraph Group | Venture Capital | Minority | ||
| Titan Angels | Angel Group | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator |
Synova Life Sciences FAQs
-
When was Synova Life Sciences founded?
Synova Life Sciences was founded in 2013.
-
Where is Synova Life Sciences headquartered?
Synova Life Sciences is headquartered in Pasadena, CA.
-
What is the size of Synova Life Sciences?
Synova Life Sciences has 6 total employees.
-
What industry is Synova Life Sciences in?
Synova Life Sciences’s primary industry is Other Devices and Supplies.
-
Is Synova Life Sciences a private or public company?
Synova Life Sciences is a Private company.
-
What is Synova Life Sciences’s current revenue?
The current revenue for Synova Life Sciences is .
-
How much funding has Synova Life Sciences raised over time?
Synova Life Sciences has raised $2.48M.
-
Who are Synova Life Sciences’s investors?
McNamara Investments, Unpopular Ventures, Seraph Group, Titan Angels, and Creative Destruction Lab are 5 of 14 investors who have invested in Synova Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process